A Rajput

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. doi request reprint Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer
    Ashwani Rajput
    Division of Surgical Oncology, Department of Surgery, University of New Mexico, Albuquerque, NM University of New Mexico Comprehensive Cancer Center, Albuquerque, NM Electronic address
    Clin Colorectal Cancer . 2016
  2. pmc Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines
    Sanjib Chowdhury
    Eppley Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA
    PLoS ONE 8:e60299. 2013
  3. doi request reprint Pediatric melanoma in New Mexico American Indians, Hispanics, and non-Hispanic whites, 1981-2009
    Ashwani Rajput
    Division of Surgical Oncology, Department of Surgery, University of New Mexico, Albuquerque, NM 87131, USA Electronic address
    Am J Surg 207:412-6; discussion 416. 2014
  4. pmc Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells
    Neka A K Simms
    Eppley Institute for Research in Cancer and Allied Diseases, University at Nebraska Medical Center, Omaha, USA
    BMC Cancer 12:221. 2012
  5. doi request reprint Meeting the 12 lymph node (LN) benchmark in colon cancer
    A Rajput
    Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA
    J Surg Oncol 102:3-9. 2010
  6. ncbi request reprint Lymph node retrieval rates affect adjuvant chemotherapy (AC) utilization for stage II colon cancer at the National Comprehensive Cancer Network (NCCN) institutions
    C C Earle
    Dana Farber Cancer Institute, Boston, MA Memorial Sloan Kettering Cancer Center, New York, NY City of Hope National Medical Center, Duarte, CA University of Texas M D Anderson Cancer Center, Houston, TX Ohio State University, Columbus, OH Roswell Park Cancer Institute, Buffalo, NY Fox Chase Cancer Center, Philadelphia, PA
    J Clin Oncol 26:4046. 2008
  7. ncbi request reprint How often is adjuvant FOLFOX (Adj FOLFOX) discontinued for toxicity among colon cancer patients in the routine care setting?
    D Romanus
    Dana Farber Cancer Institute, Boston, MA Memorial Sloan Kettering Cancer Center, New York, NY City of Hope National Medical Center, Duarte, CA M D Anderson Cancer Center, Houston, TX The Ohio State University, Columbus, OH Roswell Park Cancer Institute, Buffalo, NY Fox Chase Cancer Center, Philadelphia, PA Robert H Lurie Comprehensive Cancer Center, Chicago, IL
    J Clin Oncol 27:9530. 2009

Collaborators

  • D Schrag
  • Itzhak Nir
  • C C Earle
  • Sanjib Chowdhury
  • Michael G Brattain
  • Jing Wang
  • Melanie Ongchin
  • Neka A K Simms
  • D Romanus
  • Elizabeth Sharratt
  • Ivan Dominguez
  • Carol A Teggart
  • Elizabeth A Sharratt
  • M Weiser
  • J Skibber
  • A Terveer
  • Y Wong
  • J Wilson
  • A Benson
  • J Niland

Detail Information

Publications7

  1. doi request reprint Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer
    Ashwani Rajput
    Division of Surgical Oncology, Department of Surgery, University of New Mexico, Albuquerque, NM University of New Mexico Comprehensive Cancer Center, Albuquerque, NM Electronic address
    Clin Colorectal Cancer . 2016
    ....
  2. pmc Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines
    Sanjib Chowdhury
    Eppley Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, USA
    PLoS ONE 8:e60299. 2013
    ....
  3. doi request reprint Pediatric melanoma in New Mexico American Indians, Hispanics, and non-Hispanic whites, 1981-2009
    Ashwani Rajput
    Division of Surgical Oncology, Department of Surgery, University of New Mexico, Albuquerque, NM 87131, USA Electronic address
    Am J Surg 207:412-6; discussion 416. 2014
    ..Pediatric melanoma rates are increasing nationally. Our purpose was to determine the incidence of melanoma in New Mexico's (NM's) American Indian, Hispanic, and non-Hispanic white children...
  4. pmc Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells
    Neka A K Simms
    Eppley Institute for Research in Cancer and Allied Diseases, University at Nebraska Medical Center, Omaha, USA
    BMC Cancer 12:221. 2012
    ..However, we present evidence here for an anti-metastatic role of TGFβ signaling...
  5. doi request reprint Meeting the 12 lymph node (LN) benchmark in colon cancer
    A Rajput
    Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA
    J Surg Oncol 102:3-9. 2010
    ..Examining >or=12 LN in colon cancer has been suggested as a quality metric. The purpose of this study was to determine whether the 12 LN benchmark is achieved at NCCN centers compared to a US population-based sample...
  6. ncbi request reprint Lymph node retrieval rates affect adjuvant chemotherapy (AC) utilization for stage II colon cancer at the National Comprehensive Cancer Network (NCCN) institutions
    C C Earle
    Dana Farber Cancer Institute, Boston, MA Memorial Sloan Kettering Cancer Center, New York, NY City of Hope National Medical Center, Duarte, CA University of Texas M D Anderson Cancer Center, Houston, TX Ohio State University, Columbus, OH Roswell Park Cancer Institute, Buffalo, NY Fox Chase Cancer Center, Philadelphia, PA
    J Clin Oncol 26:4046. 2008
    ..4046 Background: The decision to take AC in stage II colon cancer requires weighing uncertain benefits with the potential for acute and, increasingly, long-term toxicity...
  7. ncbi request reprint How often is adjuvant FOLFOX (Adj FOLFOX) discontinued for toxicity among colon cancer patients in the routine care setting?
    D Romanus
    Dana Farber Cancer Institute, Boston, MA Memorial Sloan Kettering Cancer Center, New York, NY City of Hope National Medical Center, Duarte, CA M D Anderson Cancer Center, Houston, TX The Ohio State University, Columbus, OH Roswell Park Cancer Institute, Buffalo, NY Fox Chase Cancer Center, Philadelphia, PA Robert H Lurie Comprehensive Cancer Center, Chicago, IL
    J Clin Oncol 27:9530. 2009
    ..We used the NCCN Colorectal Cancer Outcomes Database to identify how frequently Adj FOLFOX is discontinued prematurely for toxicity in a non-clinical trial population...